Clinical Trials in Detroit

Showing 9661-9680 of 19,719 trials

Fetal Pulse Oximetry Trial (FOX)

NCT00098709

The purpose of this study is to determine if the information provided to the physician by a fetal pulse oximeter during labor will reduce the chances of a cesarean delivery.

Pregnancy

The George Washington University Biostatistics Center10,000 participantsStarted May 2002

Birmingham, Alabama, United States • Chicago, Illinois, United States • Detroit, Michigan, United States +10 more locations

COMPLETEDPhase 3< 1 mile

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

NCT01231516

ING111762 is a 48 week, randomized, double-blind, active-controlled, multicenter, parallel group, non-inferiority study. The study will be conducted in at least 688 HIV-1 infected antiretroviral experienced, integrase-naïve subjects. Subjects will be randomized 1:1 to receive GSK1349572 50 mg once daily or raltegravir (RAL) 400 mg twice daily, each added to an investigator selected background regimen consisting of at least one fully active agent plus no more than one second single agent which may or may not be active. Antiviral activity, safety, pharmacokinetics (PK), and development of viral resistance will be evaluated.

Infection, Human Immunodeficiency VirusHIV Infections

ViiV Healthcare724 participantsStarted Oct 2010

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +177 more locations

Fetal Pulse Oximetry Trial (FOX)

A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults

Find Trials by Condition in Detroit

Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection

Feasibility and Efficacy of a Brief Mindfulness-Based Intervention SMOKING INTERVENTION VIA THE INTERNET

An Efficacy and Safety Study Of Pracinostat In Combination With Azacitidine In Adults With Acute Myeloid Leukemia

A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma

Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Blood Culture Improvement Guidelines and Diagnostic Stewardship for Antibiotic Reduction in Critically Ill Children

Narcotic vs. Non-narcotic Pain Study Protocol

A Safety Study of LY3462817 and LY3509754 in Participants With Psoriasis

Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma

Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.

Adaptive COVID-19 Treatment Trial (ACTT)

Adaptive COVID-19 Treatment Trial 2 (ACTT-2)

A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis

A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

CALERIE: Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy

Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia